Discovery of Prodrug of MRTX1133 as an Oral Therapy for Cancers with KRASG12D Mutation
Authors:
Open Access
- 9 February 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8 (7) , 7211-7221
Abstract
Effective oral therapies are urgently required to treat KRASG12D mutant cancers. Therefore, synthesis and screening were performed for 38 prodrugs of MRTX1133 to identify an oral prodrug of MRTX1133, a KRASG12D mutant protein-specific inhibitor. In vitro and in vivo evaluations revealed prodrug 9 as the first orally available KRASG12D inhibitor. Prodrug 9 exhibited improved pharmacokinetic properties for the parent compound in mice and was efficacious in a KRASG12D mutant xenograft mouse tumor model after oral administration.Keywords
Funding Information
- Risen (Shanghai) Pharmaceutical Technology Co. Ltd.
This publication has 30 references indexed in Scilit:
- Synthesis, Biological Evaluation, and Pharmacokinetic Study of Novel Liguzinediol ProdrugsMolecules, 2013
- A Comprehensive Survey of Ras Mutations in CancerCancer Research, 2012
- Overcoming poor permeability – the role of prodrugs for oral drug deliveryDrug Discovery Today: Technologies, 2012
- Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidineBritish Journal of Clinical Pharmacology, 2010
- Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety AttributesACS Chemical Neuroscience, 2010
- Arbaclofen Placarbil, a Novel R-Baclofen Prodrug: Improved Absorption, Distribution, Metabolism, and Elimination Properties Compared with R-BaclofenThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Prodrugs: design and clinical applicationsNature Reviews Drug Discovery, 2008
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Advanced Drug Delivery Reviews, 2001
- Synthesis of a Novel Esterase-Sensitive Cyclic Prodrug of a Hexapeptide Using an (Acyloxy)alkoxy PromoietyThe Journal of Organic Chemistry, 1997
- ras GENESAnnual Review of Biochemistry, 1987